• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童肝脏药物清除率:以吲哚菁绿作为模型底物的研究

Hepatic drug clearance in children: studies with indocyanine green as a model substrate.

作者信息

Evans W E, Relling M V, de Graaf S, Rodman J H, Pieper J A, Christensen M L, Crom W R

机构信息

Pharmacokinetics and Pharmacodynamics Section, St. Jude Children's Research Hospital, Memphis, TN.

出版信息

J Pharm Sci. 1989 Jun;78(6):452-6. doi: 10.1002/jps.2600780605.

DOI:10.1002/jps.2600780605
PMID:2760818
Abstract

For several drugs metabolized by the liver, higher dosages (mg/kg body weight) are required in children to attain serum concentrations comparable to those in adults. Indocyanine green (ICG), a commonly used model substrate for hepatic elimination of high intrinsic clearance drugs, has been extensively evaluated in adults but not in children. We evaluated the disposition of ICG in 115 children with leukemia and nine healthy adult volunteers. The mean (SD) ICG plasma clearance (CLp) for all 115 children (age 0.9-17.8 years) was significantly greater (p = 0.0006) than for adults [14.8 (7.8) versus 10.6 (2.4) mL/min/kg]. When clearances from only children less than 10 years of age (N = 85) were compared with those from adults, the difference was even greater [15.6 (7.3) versus 10.6 (2.4) mL/min/kg; p = 0.0001]. However, when ICG CLp was normalized to body surface area, values for children did not differ significantly from adults [378 (204) versus 422 (102) mL/min/m2]. These data provide insight as to why dosage (mg/kg) requirements of certain drugs are higher in children.

摘要

对于几种经肝脏代谢的药物,儿童需要更高的剂量(毫克/千克体重)才能达到与成人相当的血清浓度。吲哚菁绿(ICG)是一种常用于肝脏清除高内在清除率药物的模型底物,已在成人中得到广泛评估,但尚未在儿童中进行评估。我们评估了115名白血病儿童和9名健康成人志愿者体内ICG的处置情况。115名儿童(年龄0.9 - 17.8岁)的平均(标准差)ICG血浆清除率(CLp)显著高于成人(p = 0.0006)[14.8(7.8)对10.6(2.4)毫升/分钟/千克]。当仅将10岁以下儿童(N = 85)的清除率与成人的清除率进行比较时,差异更大[15.6(7.3)对10.6(2.4)毫升/分钟/千克;p = 0.0001]。然而,当ICG的CLp按体表面积进行标准化时,儿童的值与成人的值没有显著差异[378(204)对422(102)毫升/分钟/平方米]。这些数据为某些药物在儿童中需要更高剂量(毫克/千克)的原因提供了见解。

相似文献

1
Hepatic drug clearance in children: studies with indocyanine green as a model substrate.儿童肝脏药物清除率:以吲哚菁绿作为模型底物的研究
J Pharm Sci. 1989 Jun;78(6):452-6. doi: 10.1002/jps.2600780605.
2
Liver volume as a determinant of drug clearance in children and adolescents.
Drug Metab Dispos. 1995 Oct;23(10):1110-6.
3
Antipyrine, oxazepam, and indocyanine green clearance in patients with chronic pancreatitis and healthy subjects.
Scand J Gastroenterol. 1999 Aug;34(8):813-7. doi: 10.1080/003655299750025750.
4
Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrine.
Clin Pharmacol Ther. 1991 Aug;50(2):132-40. doi: 10.1038/clpt.1991.117.
5
Hepatic drug clearance: the effect of age using indocyanine green as a model compound.肝脏药物清除率:以吲哚菁绿为模型化合物研究年龄的影响。
Br J Clin Pharmacol. 1990 Oct;30(4):634-7. doi: 10.1111/j.1365-2125.1990.tb03826.x.
6
Enhancement of unbound clearance of ICG by plasma proteins, demonstrated in human subjects and interpreted without assumption of facilitating structures.
J Hepatol. 1993 Nov;19(3):327-44. doi: 10.1016/s0168-8278(05)80541-0.
7
Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia.克拉屈滨(2-氯脱氧腺苷)在儿童急性白血病中的药代动力学。
Cancer Res. 1994 Mar 1;54(5):1235-9.
8
Intrinsic hepatic clearance of indocyanine green in the pig: dependence on plasma protein concentration.猪体内吲哚菁绿的肝内清除率:对血浆蛋白浓度的依赖性。
Eur J Clin Invest. 1992 May;22(5):347-57. doi: 10.1111/j.1365-2362.1992.tb01473.x.
9
Exposure to high environmental temperature in the sauna does not change plasma indocyanine green (ICG) clearance in healthy subjects.在桑拿浴中暴露于高温环境不会改变健康受试者的血浆吲哚菁绿(ICG)清除率。
Pharmacol Toxicol. 1996 Feb;78(2):94-8. doi: 10.1111/j.1600-0773.1996.tb00187.x.
10
Developmental changes in the liver weight- and body weight-normalized clearance of theophylline, phenytoin and cyclosporine in children.儿童体内茶碱、苯妥英和环孢素经肝脏重量和体重标准化后的清除率的发育变化。
Int J Clin Pharmacol Ther. 2002 Nov;40(11):485-92. doi: 10.5414/cpp40485.

引用本文的文献

1
Indocyanine Green Fluorescence Navigation in Pediatric Hepatobiliary Surgery: Systematic Review.小儿肝胆外科中的吲哚菁绿荧光导航:系统评价
Children (Basel). 2025 Jul 18;12(7):950. doi: 10.3390/children12070950.
2
Identification of Pediatric Tumors Intraoperatively Using Indocyanine Green (ICG).术中使用吲哚菁绿(ICG)识别儿童肿瘤。
Ann Surg Oncol. 2023 Nov;30(12):7789-7798. doi: 10.1245/s10434-023-13953-y. Epub 2023 Aug 5.
3
Indocyanine Green-Guided Pediatric Tumor Resection: Approach, Utility, and Challenges.吲哚菁绿引导下的小儿肿瘤切除术:方法、效用及挑战
Front Pediatr. 2021 Sep 20;9:689612. doi: 10.3389/fped.2021.689612. eCollection 2021.
4
Mechanical thrombectomy in children and adolescents: report of five cases and literature review.儿童和青少年机械取栓术:5 例报告及文献复习。
Stroke Vasc Neurol. 2018 Nov 12;3(4):245-252. doi: 10.1136/svn-2018-000181. eCollection 2018 Dec.
5
Clearance of Indocyanine Green in Severe Pediatric Burns.小儿严重烧伤患者吲哚菁绿清除率的研究。
J Trauma Acute Care Surg. 2019 May;86(5):817-822. doi: 10.1097/TA.0000000000002180.
6
Intravenous Thrombolysis at 3.5 Hours From Onset of Pediatric Acute Ischemic Stroke.小儿急性缺血性卒中发病3.5小时内的静脉溶栓治疗。
Pediatr Emerg Care. 2020 Jan;36(1):e4-e7. doi: 10.1097/PEC.0000000000001419.
7
Thrombolysis in pediatric stroke study.小儿卒中溶栓研究
Stroke. 2015 Mar;46(3):880-5. doi: 10.1161/STROKEAHA.114.008210. Epub 2015 Jan 22.
8
Effects of body size and gender on the population pharmacokinetics of artesunate and its active metabolite dihydroartemisinin in pediatric malaria patients.体型和性别对小儿疟疾患者青蒿琥酯及其活性代谢物双氢青蒿素群体药代动力学的影响。
Antimicrob Agents Chemother. 2013 Dec;57(12):5889-900. doi: 10.1128/AAC.00635-13. Epub 2013 Sep 16.
9
RNA-Seq reveals different mRNA abundance of transporters and their alternative transcript isoforms during liver development.RNA-Seq 揭示了肝发育过程中转运蛋白及其替代转录本异构体的 mRNA 丰度存在差异。
Toxicol Sci. 2012 Jun;127(2):592-608. doi: 10.1093/toxsci/kfs107. Epub 2012 Mar 27.
10
Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure.卡维地洛在充血性心力衰竭患儿中的群体药代动力学及剂量模拟
Br J Clin Pharmacol. 2008 Apr;65(4):511-22. doi: 10.1111/j.1365-2125.2007.03046.x. Epub 2007 Nov 8.